Screener
SG&A at other companies
Other financials
Where this comes from
Reported directly by Guardian Pharmacy Services in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Guardian Pharmacy Services’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338074
| (In thousands, except per share amounts) | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2026 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2026 |
|---|---|---|---|---|
| Revenues | $344,334 | $351,768 | $673,642 | $688,363 |
| Cost of goods sold | 276,188 | 271,724 | 541,147 | 532,010 |
| Gross profit | 68,146 | 80,044 | 132,495 | 156,353 |
| Selling, general, and administrative expenses | 55,566 | 59,400 | 106,910 | 118,034 |
| Operating income | 12,580 | 20,644 | 25,585 | 38,319 |
| Other expenses (income): | ||||
| Interest expense | 172 | 154 | 342 | 308 |
| Other expense (income), net | (179) | (9,302) | (450) | (10,074) |
ITEM 1. Financial Statements
FAQ
- What is Guardian Pharmacy Services's SG&A?
- Guardian Pharmacy Services (GRDN) reported SG&A of $59.4M in Q2 2026.
- How has Guardian Pharmacy Services's SG&A changed year-over-year?
- Guardian Pharmacy Services's SG&A increased by 6.9% year-over-year, from $55.57M to $59.4M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about Guardian Pharmacy Services's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude